Insulin Resistance Is Mediated by a Proteolytic Fragment of the Insulin Receptor (*)
- ↵§ To whom correspondence should be addressed: Dept. of Pharmacology, University of Texas Medical School, 6431 Fannin, P. O. Box 20708, Houston, TX 77225. Tel.: 713-792-5975; Fax: 713-792-5911.
Abstract
Insulin resistance is a common clinical feature of obesity and non-insulin-dependent diabetes mellitus, and is characterized by elevated serum levels of glucose, insulin, and lipids. The mechanism by which insulin resistance is acquired is unknown. We have previously demonstrated that upon chronic treatment of fibroblasts with insulin, conditions that mimic the hyperinsulinemia associated with insulin resistance, the membrane-associated insulin receptor β subunit is proteolytically cleaved, resulting in the generation of a cytosolic fragment of the β subunit, β‘, and that the generation of β‘ is inhibited by the thiol protease inhibitor E64 (Knutson, V. P.(1991) J. Biol. Chem. 266, 15656-15662). In this report, we demonstrate that in 3T3-L1 adipocytes: 1) cytosolic β‘ is generated by chronic insulin administration to the cells, and that E64 inhibits the production of β‘; 2) chronic administration of insulin to the adipocytes leads to an insulin-resistant state, as measured by lipogenesis and glycogen synthesis, and E64 totally prevents the generation of this insulin-induced cellular insulin resistance; 3) E64 has no effect on the insulin-induced down-regulation of insulin receptor substrate-1, and therefore insulin resistance is not mediated by the down-regulation of insulin receptor substrate-1; 4) under in vitro conditions, partially purified β‘ stoichiometrically inhibits the insulin-induced autophosphorylation of the insulin receptor β subunit; and 5) administration of E64 to obese Zucker fatty rats improves the insulin resistance of the rats compared to saline-treated animals. These data indicate that β‘ is a mediator of insulin resistance, and the mechanism of action of β‘ is the inhibition of the insulin-induced autophosphorylation of the β subunit of the insulin receptor.
Footnotes
-
↵* This work was supported by Grant DK35397 from the National Institutes of Health and Grant IBN-9105624 from the National Science Foundation. This work was done during the tenure of an Established Investigatorship Award from the American Heart Association and Sandoz Pharmaceuticals Corporation (to V. P. K.). This material is based in part upon work supported by the Texas Advanced Research Program under Grant 011618-056. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
1 The abbreviations used are:
- IRS-1
- insulin receptor substrate-1
- PAGE
- polyacrylamide gel electrophoresis.
-
2V. P. Knutson, Y. Balba, and T. Elliott, submitted for publication.
-
3V. P. Knutson, P. V. Donnelly, Y. Balba, and M. Lopez-Reyes, manuscript in preparation.
- Received July 31, 1995.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











